|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
10 months to Dec 31, 2022
|
|
|---|---|---|---|
| Operating activities | |||
| Net increase (decrease) in net assets resulting from operations | |||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | |||
| Purchases of investments | |||
| Proceeds from disposition of investments | |||
| Net realized (gain) loss on investments | |||
| Net realized (gain) loss on foreign currency investments | |||
| Net realized (gain) loss on foreign currency debt | |||
| Change in net unrealized (appreciation)/depreciation of investments | |||
| Change in net unrealized (appreciation)/depreciation of foreign currency investments | |||
| Change in net unrealized (appreciation)/depreciation of foreign currency debt | |||
| Net amortization of investment discounts and premiums | |||
| Amortization of deferred debt issuance costs | |||
| PIK interest and other income capitalized | |||
| Changes in assets and liabilities: | |||
| Decrease (increase) in interest receivable | |||
| Decrease (increase) in derivatives, at fair value | |||
| Decrease (increase) in receivables for investments sold | |||
| Decrease (increase) in interest and other receivables | |||
| Decrease (increase) in prepaid expenses and other assets | |||
| Increase (decrease) in incentive fees payable | |||
| Increase (decrease) in interest and other debt related payables | |||
| Increase (decrease) in payable to broker | |||
| Increase (decrease) in payable for investments purchased | |||
| Increase (decrease) in management fees payable | |||
| Increase (decrease) in accrued expenses and other liabilities | |||
| Net cash provided by (used in) operating activities | |||
| Financing activities | |||
| Proceeds from shares of common stock sold | |||
| Debt borrowings | |||
| Debt repayments | |||
| Distribution paid | |||
| Deferred debt issuance costs paid | |||
| Net cash provided by (used in) financing activities | |||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||
| Cash and cash equivalents and restricted cash at beginning of period | |||
| Cash and cash equivalents and restricted cash at end of period | |||
| Supplemental information | |||
| Interest and other debt expenses paid | |||
| Upfront fees paid | |||
| Other financing fees paid | |||
| Supplemental non-cash information | |||
| Reinvestment of shareholder distributions |
Loading...
